Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT04908423
PHASE4

Xeomin® and Gait Related Mobility After Stroke

Sponsor: Wake Forest University Health Sciences

View on ClinicalTrials.gov

Summary

The aim of the present pilot study is to evaluate the association between change in gait related mobility in ambulatory male and female adult hemiparetic patients before and 4-6-weeks after Xeomin® injection into the upper limb, using two standardized tests of physical function in outpatient rehabilitation that are widely used; the 10-meter walk test and the timed 'up and go' test (TUG).

Official title: Upper Extremity Injection of Xeomin® and Changes in Gait Related Mobility in Adults After Stroke

Key Details

Gender

All

Age Range

18 Years - 79 Years

Study Type

INTERVENTIONAL

Enrollment

20

Start Date

2021-10-19

Completion Date

2027-04

Last Updated

2025-11-25

Healthy Volunteers

No

Conditions

Interventions

DRUG

Xeomin®

To discover whether injection into the upper extremity with Xeomin® triggers improvements in gait-related mobility and quality of life in adults with hemiparesis secondary to stroke.

Locations (1)

Carolinas Rehabilitation

Charlotte, North Carolina, United States